Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Trading Statement

13 Feb 2008 09:40

Imaginatik PLC13 February 2008 13 February 2008 Imaginatik plc ("Imaginatik" or the "Company") Trading Update Imaginatik plc (AIM: IMTK), a leading provider of collaborative innovation andproblem-solving software and processes announces today that an improved tradingperformance in the second half of the year should result in a profit for thisperiod. This outcome is expected to strengthen the balance sheet and provide apositive operating cash flow for the second half year. The Company's recurringrevenue base continues to build well and will help underpin our operations intothe next financial year. In view of the weak trading experienced in the first half of the financial yearand not withstanding the much improved performance in the second half year, theCompany is unlikely to reach the market forecast of £4.4m of revenue for theyear to 31 March 2008. Overheads continue to be tightly contained. As a resultthe level of business required to reach break-even for the full year has beensignificantly reduced. Imaginatik also announces today that it is in final negotiations with a majorcustomer which may or may not lead to it becoming a strategic investor in theCompany. The Board will provide additional information to the market as soon asthe agreement is concluded. Mark Turrell, CEO of Imaginatik plc, commented, "I am pleased to see theCompany's performance improving after a difficult first nine months as a publiccompany. We now have a great deal of momentum within the business, our pipelineis strong and our recent presence at the World Economic Forum in Davos will helpaccelerate the current level of activity. We believe having a significantstrategic investor on board would be extremely positive for Imaginatik and itsshareholders and we will provide further information in due course." For further information please contact: Imaginatik plc Tel: +44 (0)20 7917 2975Mark Turrell, CEO / Shawn Taylor, CFO WH Ireland Tel: +44 (0)121 265 6330Tim Cofman/Katy Birkin Investor relations and UK mediaICIS Tel: +44 (0)20 7651 8688Tom Moriarty / Caroline Evans Jones About Imaginatik Imaginatik is the leading provider of Collaborative Innovation and ProblemSolving software and process to the world's leading companies. More than 100clients, including Hewlett-Packard, IBM and Pfizer, rely on Imaginatik'ssoftware, consulting and research to enable their best-of-breed innovationactivities. Imaginatik's software and consulting services have helped clients discoversignificant sources of additional revenue, as well as tangible cost savings,process improvements and increased product pipeline. Imaginatik is alsocommitted to developing strategic solutions in the field of innovation, workingwith academic institutions such as the London Business School and the CassSchool of Business, London, as well as leading practitioners of corporateinnovation. For further information please visit www.imaginatik.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Nov 20137:00 amRNSHalf Yearly Report
24th Oct 20137:00 amRNSContract Win
10th Oct 201310:01 amRNSHolding(s) in Company
2nd Oct 20137:00 amRNSIssue of Equity
1st Oct 201310:03 amRNSTransaction in Own Shares/Director's Dealing
23rd Sep 20137:00 amRNSContract Win with Shell
18th Sep 20132:03 pmRNSResult of AGM
27th Aug 20131:50 pmRNSNotice of AGM
24th Jul 20137:00 amRNSFinal Results
8th Jul 20137:00 amRNSContract Win
1st Jul 20137:00 amRNSChange of Adviser
21st Jun 20137:00 amRNSBoard Changes
13th Jun 20137:00 amRNSConsultancy Update
31st May 20137:00 amRNSTotal Voting Rights
16th May 20131:03 pmRNSHolding(s) in Company
16th May 20137:00 amRNSHolding(s) in Company
13th May 201312:16 pmRNSResult of General Meeting
26th Apr 20134:52 pmRNSPublication of Circular
26th Apr 20137:00 amRNSProposed Placing
16th Apr 201312:20 pmRNSCapital Market Strategy Update
7th Feb 20132:25 pmRNSTrading Update
10th Dec 20127:00 amRNSContract Wins
22nd Nov 20127:00 amRNSShare Options
21st Nov 20127:00 amRNSHalf Yearly Report
25th Oct 20127:00 amRNSTrading Update
2nd Oct 20127:00 amRNSLitigation Conclusion
14th Sep 20121:02 pmRNSResult of AGM
14th Sep 20127:00 amRNSAGM Statement
23rd Aug 20127:00 amRNSNotice of AGM
4th Jul 201212:04 pmRNSHolding(s) in Company
2nd Jul 20122:22 pmRNSHolding(s) in Company
29th Jun 20123:30 pmRNSHolding(s) in Company
29th Jun 201212:12 pmRNSHolding(s) in Company
28th Jun 20121:36 pmRNSHolding(s) in Company
27th Jun 201211:20 amRNSResult of General Meeting
20th Jun 20121:41 pmRNSDirectorate Change
11th Jun 20128:30 amRNSDirector/PDMR Shareholding
11th Jun 20128:00 amRNSFinal Results
11th Jun 20128:00 amRNSProposed Placing
17th Apr 20127:00 amRNSContract Wins
17th Apr 20127:00 amRNSTrading Update
29th Feb 20127:00 amRNSContract with US Healthcare Services Provider
21st Feb 20121:45 pmRNSHolding(s) in Company
20th Feb 201212:54 pmRNSHolding(s) in Company
15th Feb 201212:16 pmRNSHolding(s) in Company
15th Feb 20127:00 amRNSShare Option Schemes
8th Feb 20127:00 amRNSIssue of Equity
3rd Feb 201211:39 amRNSHolding(s) in Company
2nd Feb 201210:49 amRNSHolding(s) in Company
30th Jan 20127:00 amRNSSenior Management Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.